Transgene Will Present Oncolytic Virus Data in Phoenix
The company will debut preclinical results for its systemically delivered PoxSTG-EEV candidate on November 7, 2026.
Phoenix Biotech
Recent news
October 4, 2026
Ocugen CEO Will Discuss Gene Therapy Outlook in PhoenixThe company’s executive will present on commercialization efforts at the upcoming Cell & Gene Meeting on the Mesa.
September 24, 2026
BOOST Pharma Will Present BT-101 Data in OctoberThe clinical-stage firm will discuss its allogeneic stem cell therapy for osteogenesis imperfecta in Phoenix.